Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 1, 2008, Pages 105-109

  Casale, Thomas B ^a   Romero, Francisco A ^a   Spierings, Egilius L H ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

allergic rhinitis; Carbon dioxide; clinical trial; topical nasal administration

Indexed keywords

CARBON DIOXIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HAY FEVER; HUMAN; LARYNGITIS; MAJOR CLINICAL STUDY; MUSCLE CRAMP; NASAL PRURITUS; NOSE BURNING; NOSE CARTILAGE; NOSE CONGESTION; NOSE STINGING; PALLIATIVE THERAPY; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SNEEZING; STATISTICAL SIGNIFICANCE; SYMPTOM; THERAPY EFFECT; TREATMENT RESPONSE; WATERY EYE;

ADMINISTRATION, INTRANASAL; ADULT; CARBON DIOXIDE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INHALATION; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 38149042565     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.056     Document Type: Article

References (18)

1. Plaut M., and Valentine M.D. Allergic rhinitis. N Engl J Med 353 (2005) 1934-1944
2. Dykewicz M.S., Fineman S., Skoner D.P., Nicklas R., Lee R., Blessing-Moore J., et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 81 (1998) 478-518
3. Lai L., Casale T.B., and Stokes J. Pediatric allergic rhinitis: treatment. Immunol Allergy Clin North Am 25 (2005) 283-299
4. Stempel D.A., and Woolf R. The cost of treating allergic rhinitis. Curr Allergy Asthma Rep 2 (2002) 223-230
5. Schoenwetter W.F., Dupclay L., Appajosyula S., Botteman M.F., and Pashos C.L. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 20 (2004) 305-317
6. Juniper E.F., Guyatt G.H., Ferrie P.J., and Griffith L.E. First-line treatment of seasonal (ragweed) rhinoconjunctivitis. CMAJ 156 (1997) 1123-1131
7. White P., Smith H., Baker N., Davis W., and Frew A. Symptom control in patients with hay fever in UK general practice. Clin Exp Allergy 28 (1998) 266-270
8. Spierings E.L.H. Abortive treatment of migraine headache with non-inhaled intranasal carbon dioxide: a randomized, double-blind, placebo-controlled, parallel-group study. [abstract]. Headache 45 (2005) 809
9. Spierings ELH. Non-inhaled, intranasal carbon dioxide for the abortive treatment of migraine headache: efficacy, tolerability, and safety. Abstract presented at the 130th Annual Meeting of the American Neurological Association; September 25-28, 2005; San Diego, Calif.
10. Goadsby P.J., Edvinsson L., and Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28 (1990) 183-187
11. Bellamy J.L., Cady R.K., and Durham P.L. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache 46 (2006) 24-33
12. Bowen E.J., Niemann C.C., and Durham P.L. Carbon dioxide regulation of CGRP secretion from trigeminal neurons. [abstract]. Headache 45 (2005) 808
13. Lacroix J.S. Chronic rhinosinusitis and neuropeptides. Swiss Med Weekly 133 (2003) 560-562
14. Undem B.J., Kajekar R., Hunter D.D., and Myers A.C. Neural integration and allergic disease. J Allergy Clin Immunol 106 suppl (2000) S213-S220
15. Walker K.B., Serwonska M.H., Valone F.H., Harkonen W.S., Frick O.L., Scriven K.H., et al. Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen. J Clin Immunol 8 (1988) 108-113
16. Mosimann B.L., White M.V., Hohman R.J., Goldrich M.S., Kaulbach H.C., and Kaliner M.A. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 92 (1993) 95-104
17. Bauer O., and Razin E. Mast cell-nerve interactions. News Physiol Sci 15 (2000) 213-218
18. Dolen W.K. Antihistamine onset of action: the importance to the patient. Allergy Asthma Proc 25 (2004) 85-87